Form 4 Filing for BioStem Technologies, Inc.

This filing details transactions related to securities of BioStem Technologies, Inc. Andrew Smith-Van Vurst, Chief Operating Officer, Director, and 10% owner, reported the acquisition of 7,622 shares of Common Stock on September 15, 2026, and an additional 9,574 shares on September 17, 2026. These acquisitions were made at a price of $0.00 per share. Additionally, the filing includes the disposition of 7,622 Restricted Stock Units (RSUs) on September 15, 2026, and 9,574 RSUs on September 17, 2026. The RSUs disposed of were valued at $0.00 per share, with the underlying securities being shares of Common Stock. The filing also includes a Power of Attorney document authorizing representatives to handle SEC filings and manage the company's EDGAR account.